Molly Blake-Michaels, Consulting Solutions Expert, Oracle Health Sciences

Under the current global operating environment, biopharmaceutical and medical device companies face far more limited financial resources, while time-to-market pressures are intensifying and worldwide clinical research activity is rising steadily. In response, companies are placing more demand on their planning and forecasting processes and capabilities and setting lower tolerances for variance between planned and actual performance.

Under the current global operating environment, biopharmaceutical and medical device companies face far more limited financial resources, while time-to-market pressures are intensifying and worldwide clinical research activity is rising steadily. In response, companies are placing more demand on their planning and forecasting processes and capabilities and setting lower tolerances for variance between planned and actual performance.